Tourette's syndrome

New England Journal of Medicine

Volumn 345, Issue 16, 2001, Pages 1184-1192

  Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CANNABINOID; CENTRAL STIMULANT AGENT; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPHENAZINE; HALOPERIDOL; METHYLPHENIDATE; MOLINDONE; NEUROLEPTIC AGENT; NICOTINE; NICOTINE GUM; OLANZAPINE; PEMOLINE; PERGOLIDE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTRALINE; TETRABENAZINE; THIORIDAZINE; TIAPRIDE; TIOTIXENE; TRIFLUOPERAZINE; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE;

ANOREXIA; CLINICAL TRIAL; DEPRESSION; GENETICS; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HUMAN; IMMUNOLOGY; INSOMNIA; LIVER TOXICITY; NEUROCHEMISTRY; NEUROPHYSIOLOGY; PATHOGENESIS; PHOBIA; PRIORITY JOURNAL; REVIEW; SEDATION;

ADRENERGIC ALPHA-AGONISTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE ANTAGONISTS; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TOURETTE SYNDROME;

EID: 0035909663     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra010032     Document Type: Review

References (93)

1. Tourette syndrome: Pieces of the puzzle
2. Tourette syndrome, associated conditions and the complexities of treatment
3. Current issues in Tourette syndrome
4. From Gilles de la Tourette's disease to Tourette syndrome: A history
5. An international perspective on Tourette syndrome: Selected findings from 3,500 individuals in 22 countries
6. Dermatological manifestations of Tourette syndrome and obsessive-compulsive disorder
7. Tourette's syndrome mimicking asthma
8. Phenomenology and classification of tics
9. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome
10. Paroxysmal dyskinesias: Clinical features and classification
11. Sleep and Tourette syndrome
12. Sleep and tic disorders
13. Severe motor tics causing cervical myelopathy in Tourette's syndrome
14. Definitions and classification of tic disorders
15. The Tourette Syndrome Diagnostic Confidence Index: Development and clinical associations
16. Differential diagnosis and etiology of tics
17. Transient tic disorder and the clinical spectrum of Tourette's syndrome
18. The Gilles de la Tourette syndrome: The current status
19. Course of tic severity in Tourette syndrome: The first two decades
20. Adult tics in Gilles de la Tourette's syndrome: Description and risk factors
21. Adult onset tic disorders
22. Features resembling Tourette's syndrome in developmental stutterers
23. Quantitative study of spontaneous eye blinks and eye tics in Gilles de la Tourette's syndrome
24. Saccadic performance characteristics and the behavioural neurology of Tourette's syndrome
25. Treatment of attention-deficit-hyperactivity disorder
26. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
27. Behavioral and emotional aspects of Tourette syndrome
28. Learning difficulties in children with Tourette syndrome
29. Obsessive-compulsive disorder associated with brain lesions: Clinical phenomenology, cognitive function, and anatomic correlates
30. Tourette's syndrome and migraine
31. Neuropathology in Tourette syndrome: An update
32. Neuroimaging studies of Tourette syndrome: A decade of progress
33. Equine self-mutilation syndrome (57 cases)
34. The metabolic anatomy of Tourette's syndrome
35. A functional neuroanatomy of tics in Tourette syndrome
36. Neurophysiology of tics
37. Altered cortical excitability in obsessive-compulsive disorder
38. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding
39. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome
40. High presynaptic dopaminergic activity in children with Tourette's disorder
41. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome
42. Bilineal transmission in Tourette syndrome
43. Influence of family history on clinical expression of Tourette's syndrome
44. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins
45. Perinatal factors in the expression of Tourette's syndrome: An exploratory study
46. Group A streptococcal infections and childhood neuropsychiatric disorders: Relationships and therapeutic implications
47. Antistriatal antibodies in Tourette syndrome cause neuronal dysfunction
48. Group A streptococcal infections and tic disorders in an Italian pediatric population
49. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever
50. B lymphocyte antigen D8/17: A peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?
51. Antibodies against human putamen in children with Tourette syndrome
52. Tourette's syndrome and "PANDAS": Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
53. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
54. Therapeutic implications of immunology for tics and obsessive-compulsive disorder
55. The epidemiology of tics and Tourette syndrome in children and adolescents
56. An epidemiologic study of Tourette's syndrome in a single school district
57. The Great Smoky Mountains Study of Youth: Goals, design, methods, and the prevalence of DSM-III-R disorders
58. The prevalence of Tourette syndrome in a mainstream school population
59. Behavioral treatments for Tourette syndrome and tic disorders: State of the art
60. Gilles de la Tourette syndrome
61. Rating scales and quantitative assessment of tics
62. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
63. Risperidone as a treatment for Tourette's syndrome
64. Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study
65. Long-term effects of tetrabenazine in hyperkinetic movement disorders
66. Update on the treatment of tics
67. Botulinum toxin in the treatment of tics
68. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
69. Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial
70. Stereotactic treatment of Gilles de la Tourette syndrome by igh frequency stimulation of thalamus
71. The treatment of Tourette's syndrome: Multimodal, developmental intervention
72. Problems in the management of attention-deficit-hyperactivity disorder
73. Clinical psychopharmacology for Tourette syndrome and associated disorders
74. Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder
75. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder
76. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial
77. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
78. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
79. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder
80. Role of serotonin in the paradoxical calming effect of psychostimulants in hyperactivity
81. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder
82. Guanfacine for treatment of attention-deficit hyperactivity disorder in boys
83. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder
84. Pharmacologic treatment of obsessive-compulsive disorder: Comparative studies
85. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder
86. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder
87. Biologic approaches to treatment-refractory obsessive-compulsive disorder
88. Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome
89. Fluvoxamine for the treatment of anxiety disorders in children and adolescents
90. Neurosurgical treatment of Tourette's syndrome: A critical review
91. Cingulotomy for intractable obsessive-compulsive disorder: Prospective long-term follow-up of 18 patients